LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC reduced its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 1.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,065 shares of the medical instruments supplier’s stock after selling 256 shares during the period. Allspring Global Investments Holdings LLC owned about 0.06% of LeMaitre Vascular worth $1,096,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Consolidated Planning Corp acquired a new position in LeMaitre Vascular during the 1st quarter valued at about $947,000. Johnson Investment Counsel Inc. boosted its stake in LeMaitre Vascular by 34.8% during the 1st quarter. Johnson Investment Counsel Inc. now owns 29,428 shares of the medical instruments supplier’s stock valued at $2,469,000 after purchasing an additional 7,603 shares during the period. Opal Wealth Advisors LLC acquired a new position in LeMaitre Vascular during the 1st quarter valued at about $26,000. Fifth Third Bancorp boosted its stake in LeMaitre Vascular by 2.3% during the 1st quarter. Fifth Third Bancorp now owns 10,903 shares of the medical instruments supplier’s stock valued at $915,000 after purchasing an additional 246 shares during the period. Finally, Dividend Assets Capital LLC acquired a new position in LeMaitre Vascular during the 1st quarter valued at about $3,877,000. 84.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at LeMaitre Vascular

In other news, CEO George W. Lemaitre sold 4,399 shares of the company’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $85.10, for a total value of $374,354.90. Following the completion of the sale, the chief executive officer directly owned 1,827,003 shares of the company’s stock, valued at approximately $155,477,955.30. This represents a 0.24% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Over the last ninety days, insiders have sold 100,000 shares of company stock valued at $8,556,857. Corporate insiders own 9.50% of the company’s stock.

LeMaitre Vascular Trading Up 1.1%

LeMaitre Vascular stock opened at $83.91 on Wednesday. The company has a quick ratio of 13.83, a current ratio of 16.49 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average price of $82.83 and a two-hundred day moving average price of $88.27. The firm has a market capitalization of $1.90 billion, a price-to-earnings ratio of 42.38, a PEG ratio of 2.19 and a beta of 0.82. LeMaitre Vascular, Inc. has a 52-week low of $71.42 and a 52-week high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.02). The company had revenue of $59.87 million for the quarter, compared to the consensus estimate of $57.61 million. LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The firm’s quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.44 earnings per share. Sell-side analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date was Thursday, May 15th. LeMaitre Vascular’s dividend payout ratio is currently 40.40%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.